It was proposed that alterations in GluN2B palmitoylation levels by HIP14L may contribute to activate cell death-signaling pathways in Huntington’s disease, leading to striatal atrophy and motor impairment [123]. This evidence concerns the gene ZDHHC13 and juvenile Huntington disease.